CRIS Current Research Information System

COLECCHIA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.284
AS - Asia 6.129
EU - Europa 5.082
AF - Africa 401
SA - Sud America 308
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.208
VN - Vietnam 1.820
SG - Singapore 1.586
CN - Cina 1.510
GB - Regno Unito 1.441
IT - Italia 727
DE - Germania 637
SE - Svezia 588
FR - Francia 369
HK - Hong Kong 366
IN - India 325
RU - Federazione Russa 285
UA - Ucraina 260
BR - Brasile 203
IE - Irlanda 195
ZA - Sudafrica 133
NL - Olanda 122
EE - Estonia 115
JP - Giappone 111
CI - Costa d'Avorio 102
CH - Svizzera 101
BD - Bangladesh 66
TG - Togo 65
FI - Finlandia 59
JO - Giordania 57
CA - Canada 49
KR - Corea 47
PH - Filippine 45
AR - Argentina 41
NG - Nigeria 39
BG - Bulgaria 36
TH - Thailandia 36
SC - Seychelles 34
BE - Belgio 25
PL - Polonia 25
EC - Ecuador 24
TR - Turchia 24
TW - Taiwan 24
GR - Grecia 23
ES - Italia 21
MX - Messico 17
IR - Iran 16
ID - Indonesia 15
LB - Libano 13
PK - Pakistan 13
IQ - Iraq 12
LT - Lituania 11
SA - Arabia Saudita 10
CL - Cile 8
CO - Colombia 8
HR - Croazia 8
UZ - Uzbekistan 8
PE - Perù 7
AU - Australia 6
KE - Kenya 6
AT - Austria 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
IL - Israele 5
PY - Paraguay 5
VE - Venezuela 5
BO - Bolivia 4
EG - Egitto 4
AL - Albania 3
AO - Angola 3
DK - Danimarca 3
MD - Moldavia 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
EU - Europa 2
HN - Honduras 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MM - Myanmar 2
MT - Malta 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LC - Santa Lucia 1
Totale 20.205
Salva come PNG Salva come JPEG
Città #
Southend 1.308
Singapore 1.063
Fairfield 941
Ashburn 834
Chandler 606
Woodbridge 397
Houston 373
Seattle 373
Wilmington 368
Santa Clara 353
San Jose 344
Hong Kong 337
Ho Chi Minh City 335
Dong Ket 317
Hanoi 292
Cambridge 290
Ann Arbor 276
Princeton 266
Beijing 213
Dublin 194
Boardman 167
Jacksonville 154
Nanjing 137
Bologna 131
Lauterbourg 128
Westminster 127
Padova 119
Hefei 111
Los Angeles 109
Abidjan 102
Tokyo 98
New York 94
Bern 86
Frankfurt am Main 74
Dallas 67
Berlin 66
Council Bluffs 66
Lomé 65
Saint Petersburg 62
Buffalo 60
Da Nang 59
San Diego 58
Amman 57
Medford 57
Shenyang 57
Milan 55
Haiphong 52
Dearborn 51
Jinan 48
Helsinki 47
Abeokuta 39
Changsha 37
Hebei 37
Shanghai 36
Seoul 34
Guangzhou 33
Nanchang 33
Sofia 33
Tianjin 33
Turin 33
São Paulo 31
Bremen 30
Munich 29
Redondo Beach 29
Jiaxing 27
Florence 25
Mülheim 25
Orem 24
Brussels 22
Redwood City 22
Biên Hòa 21
Falkenstein 21
Hangzhou 21
Mahé 20
Phoenix 20
Yubileyny 20
Hải Dương 19
Des Moines 18
Norwalk 18
Toronto 18
Kuban 17
Ningbo 17
Chicago 16
Falls Church 16
Mountain View 16
Xi'an 16
London 15
Pune 15
Rome 15
Wuhan 15
Bangkok 14
Brooklyn 14
Can Tho 14
Haikou 13
Shenzhen 13
Zhengzhou 13
Fuzhou 12
San Francisco 12
Taizhou 12
Charlotte 11
Totale 13.138
Salva come PNG Salva come JPEG
Nome #
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 328
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 302
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 287
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 278
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 257
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 244
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 237
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 229
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 221
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 221
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 219
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 218
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 217
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 216
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 215
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 211
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 206
Benign hepatic nodular lesions after treatment for childhood cancer 202
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 200
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 199
H 2breath testing for other gas-related syndromes 197
Gut Microbiota and Celiac Disease 194
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 192
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 191
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 189
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 188
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 184
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 181
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 179
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 179
null 179
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 176
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 176
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 175
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 174
Pharmacological modulation of MRP2 in primary biliary cirrhosis 173
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 173
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 172
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 170
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 170
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 166
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 165
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 165
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 164
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 163
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 163
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 163
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 163
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 162
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 161
Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome 161
Biliary symptoms, gallbladder motility, and cholecystectomy 160
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 160
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 157
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 156
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 155
Gut microbiota and metabolic syndrome. 153
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 151
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 151
Prognostic factors for hepatocellular carcinoma recurrence 151
Breath tests with stable isotopes: have they a role in liver transplantation? 150
Calcolosi della colecisti complicata 150
Gut microbiota and its pathophysiology in disease paradigms. 150
Management of hepatic encephalopathy: focus on antibiotic therapy 150
Safety of interferon beta treatment for chronic HCV hepatitis. 149
Serum TUDCA/UDCA concentration profiles after TUDCA oral load: A new test for intestinal transit time and bacteria overgrowth evaluation 148
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 148
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 147
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 147
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. 146
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 146
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 145
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 144
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 144
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 144
Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: A case report 143
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 143
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. 143
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 143
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation variant. Result of an open, uncontrolled , multicenter trial. 142
Salivary TUDCA concentration profiles after TUDCA oral load: a non-invasive test for intestinal transit time evaluation 141
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 141
Bacteria flora,gas and antibiotics 139
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, costipation-variant: results of a multicenter trial 136
Italian consensus conference for colonic diverticulosis and diverticular disease 136
Ecosistema intestinale: aspetti fisiopatologici e terapeutici 135
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study 134
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 133
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 133
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 129
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 129
Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease 128
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 127
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 127
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 126
Risk factors for gallstone formation during weight loss 126
Totale 17.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021646 0 0 0 0 0 0 0 0 0 0 0 646
2021/20222.583 241 119 139 156 211 143 60 119 88 149 771 387
2022/20232.529 286 355 158 324 162 195 52 134 454 61 176 172
2023/2024640 38 114 38 72 43 150 23 51 35 31 22 23
2024/20252.451 94 450 223 158 481 127 144 56 33 184 59 442
2025/20265.533 362 414 475 389 599 333 697 123 1.333 446 201 161
Totale 20.549